- Home
- SMX vs PSTV Comparison
SMX vs PSTV Comparison
Compare SMX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- PSTV
- Stock Information
- Founded
- SMX N/A
- PSTV 1996
- Country
- SMX Ireland
- PSTV United States
- Employees
- SMX N/A
- PSTV N/A
- Industry
- SMX Industrial Machinery/Components
- PSTV Medical/Dental Instruments
- Sector
- SMX Technology
- PSTV Health Care
- Exchange
- SMX Nasdaq
- PSTV Nasdaq
- Market Cap
- SMX 7.6M
- PSTV 7.9M
- IPO Year
- SMX N/A
- PSTV N/A
- Fundamental
- Price
- SMX $0.23
- PSTV $1.21
- Analyst Decision
- SMX
- PSTV Strong Buy
- Analyst Count
- SMX 0
- PSTV 2
- Target Price
- SMX N/A
- PSTV $14.00
- AVG Volume (30 Days)
- SMX 3.8M
- PSTV 131.9K
- Earning Date
- SMX 11-29-2024
- PSTV 11-14-2024
- Dividend Yield
- SMX N/A
- PSTV N/A
- EPS Growth
- SMX N/A
- PSTV N/A
- EPS
- SMX 6.43
- PSTV N/A
- Revenue
- SMX N/A
- PSTV $5,725,000.00
- Revenue This Year
- SMX N/A
- PSTV $11.13
- Revenue Next Year
- SMX N/A
- PSTV N/A
- P/E Ratio
- SMX $0.04
- PSTV N/A
- Revenue Growth
- SMX N/A
- PSTV 52.63
- 52 Week Low
- SMX $0.20
- PSTV $1.12
- 52 Week High
- SMX $102.00
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- SMX 23.12
- PSTV 42.52
- Support Level
- SMX $0.20
- PSTV $1.16
- Resistance Level
- SMX $0.29
- PSTV $1.42
- Average True Range (ATR)
- SMX 0.03
- PSTV 0.12
- MACD
- SMX 0.09
- PSTV -0.01
- Stochastic Oscillator
- SMX 22.10
- PSTV 24.32
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).